Steve Oh

Institute Prof. & Director

Agence Nationale de la Recherche

Singapore

Research Interests

Explore related searches

Professors in Tissue Engineering

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Steve Oh is an Institute Professor and Director at the Agency for Science Technology and Research in Singapore. His research focuses on innovative bioprocessing techniques for human mesenchymal stem cells, enhancing cell production through advanced microcarrier systems and microfluidic devices. He has contributed to the field through numerous publications on topics such as stem cell therapy and the implications of particulates in cell and gene therapy. His work aims to unlock the potential of regenerative medicine for clinical applications.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (5)

Khoon Lim

Prof.

University of Sydney

AUSTRALIA

View details

Jesus Shrestha

University of Sydney

AUSTRALIA

View details

Thomas Roberts

Associate Professor in Food Chemistry and Biotechnology

University of Sydney

AUSTRALIA

View details

Lindsay Davies

Karolinska Institutet

SWEDEN

View details

Andrea Ducci

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Steve Oh

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Maximising adherent cell production via customisable and dissolvable bio-polymer microcarriers

Scalable, High‐Density Expansion of Human Mesenchymal Stem Cells on Microcarriers Using the Bach Impeller in Stirred‐Tank Reactors

Particulates in CGT guidance survey results – an ISCT process development & manufacturing committee perspective on cell and gene therapy industry knowledge awareness

Insights into the fluid dynamics of the Bach impeller

Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group

Unlocking the full potential of mesenchymal stromal cell therapy for osteoarthritis through machine learning-based in silico trials

Scaling up stem cell production: harnessing the potential of microfluidic devices.

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow.

Scalable mesenchymal stem cell enrichment from bone marrow aspirate using deterministic lateral displacement (DLD) microfluidic sorting

Particulates are everywhere, but are they harmful in cell and gene therapies?

Collaborators (5)

Khoon Lim

Jesus Shrestha

Thomas Roberts

Lindsay Davies

Andrea Ducci

Make your next move.